Biogen Inc. buy Guggenheim
Start price
01.05.23
/
50%
€281.00
Target price
01.05.24
€317.14
Performance (%)
-30.50%
Price
26.04.24
€195.30
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by Guggenheim for Biogen Inc. is performing very badly with a performance of -30.50%. This prediction currently runs until 01.05.24. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | 7.014% | 7.014% |
iShares Core DAX® | 2.594% | -1.158% |
iShares Nasdaq 100 | 3.553% | -1.727% |
iShares Nikkei 225® | 0.687% | -8.354% |
iShares S&P 500 | 2.209% | -0.942% |
Comments by Guggenheim for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $350.00 price target on the stock, up previously from $270.00.
Ratings data for BIIB provided by MarketBeat